Myelodysplastic syndrome classification

Myelodysplastic syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelodysplastic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myelodysplastic syndrome classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myelodysplastic syndrome classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myelodysplastic syndrome classification
CDC on Myelodysplastic syndrome classification
Myelodysplastic syndrome classification in the news
Blogs on Myelodysplastic syndrome classification
Directions to Hospitals Treating Myelodysplastic syndrome
Risk calculators and risk factors for Myelodysplastic syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Myelodysplastic syndrome may be classified into several subtypes based on French-American-British (FAB) classification and World Health Organization (WHO) classification method.

Classification

French-American-British (FAB) classification

• Myelodysplastic syndrome may be classified according to French-American-British classification into five groups: Refractory anemia, refractory anemia with ring sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia.
• The table below lists FAB classification for myelodysplastic syndrome:

Name	Description
Refractory anemia	Less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors.
Refractory anemia with ring sideroblasts (RARS)	Less than 5% myeloblasts in the bone marrow, but distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts.
Refractory anemia with excess blasts (RAEB)	5-20% myeloblasts in the marrow.
Refractory anemia with excess blasts in transformation (RAEB-T)	21-30% myeloblasts in the marrow (>30% blasts is defined as acute myeloid leukemia).
Chronic myelomonocytic leukemia (CMML)	Less than 20% myeloblasts in the bone marrow and greater than 1*109/L monocytes in peripheral blood.

WHO classification

• Myelodysplastic syndromes may be classified according to WHO classification method into eight subtypes: Refractory anemia, refractory cytopenia with unilineage dysplasia, refractory anemia with ring sideroblasts, refractory cytopenia with multilineage dysplasia, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and unclassifiable myelodysplastic syndrome.
• The table below lists World Health Organiztion classification for myelodysplastic syndrome:

Old system	New system
Refractory anemia	Refractory cytopenia with unilineage dysplasia
Refractory anemia with ringed sideroblasts	Refractory anemia with ring sideroblasts
	Refractory cytopenia with multilineage dysplasia
Refractory anemia with excess blasts	Refractory anemias with excess blasts I and II
Refractory anemia with excess blasts in transformation I–IV	5q - syndrome
Chronic myelomonocytic leukemia	Myelodysplastic-myeloproliferative overlap syndromes
	Refractory cytopenia of childhood
	Unclassifiable myelodysplastic syndrome

References

Template:WikiDoc Sources